Nuveen Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $339M | Sell |
|
|||||
|
2024
Q3 | $722M | Buy |
|
|||||
|
2024
Q2 | $633M | Buy |
|
|||||
|
2024
Q1 | $519M | Buy |
|
|||||
|
2023
Q4 | $394M | Buy |
|
|||||
|
2023
Q3 | $326M | Sell |
|
|||||
|
2023
Q2 | $325M | Buy |
|
|||||
|
2023
Q1 | $352M | Buy |
|
|||||
|
2022
Q4 | $303M | Buy |
|
|||||
|
2022
Q3 | $264M | Sell |
|
|||||
|
2022
Q2 | $230M | Sell |
|
|||||
|
2022
Q1 | $272M | Buy |
|
|||||
|
2021
Q4 | $242M | Sell |
|
|||||
|
2021
Q3 | $234M | Buy |
|
|||||
|
2021
Q2 | $194M | Sell |
|
|||||
|
2021
Q1 | $227M | Sell |
|
|||||
|
2020
Q4 | $403M | Sell |
|
|||||
|
2020
Q3 | $910M | Sell |
|
|||||
|
2020
Q2 | $1.06B | Buy |
|
|||||
|
2020
Q1 | $593M | Buy |
|
|||||
|
2019
Q4 | $295M | Buy |
|
|||||
|
2019
Q3 | $68.5M | Sell |
|
|||||
|
2019
Q2 | $110M | Buy |
|
|||||
|
2019
Q1 | $18.1M | Buy |
|
|||||
|
2018
Q4 | $8.15M | Buy |
|
|||||
|
2018
Q3 | $8.8M | Buy |
|
|||||
|
2018
Q2 | $6.76M | Sell |
|
|||||
|
2018
Q1 | $6.8M | Sell |
|
|||||
|
2017
Q4 | $15.6M | Sell |
|
|||||
|
2017
Q3 | $19.8M | Buy |
|
|||||
|
2017
Q2 | $10.9M | Sell |
|
|||||
|
2017
Q1 | $9.41M | Buy |
|
|||||
|
2016
Q4 | $7.3M | Sell |
|
|||||
|
2016
Q3 | $8.13M | Buy |
|
|||||
|
2016
Q2 | $7.03M | Sell |
|
|||||
|
2016
Q1 | $7.39K | Sell |
|
|||||
|
2015
Q4 | $16.7K | Buy |
|
|||||
|
2015
Q3 | $14.2K | Buy |
|
|||||
|
2015
Q2 | $15.6K | Sell |
|
|||||
|
2015
Q1 | $15.5M | Buy |
|
|||||
|
2014
Q4 | $12M | Sell |
|
|||||
|
2014
Q3 | $12.8M | Sell |
|
|||||
|
2014
Q2 | $10.5M | Sell |
|
|||||
|
2014
Q1 | $15M | Sell |
|
|||||
|
2013
Q4 | $18.8M | Sell |
|
|||||
|
2013
Q3 | $23.4M | Sell |
|
|||||
|
2013
Q2 | $21.4M | Buy |
|